145 related articles for article (PubMed ID: 8932807)
21. Treatment of invasive fungal infections with amphotericin B colloidal dispersion in bone marrow transplant recipients.
Noskin G; Pietrelli L; Gurwith M; Bowden R
Bone Marrow Transplant; 1999 Apr; 23(7):697-703. PubMed ID: 10218847
[TBL] [Abstract][Full Text] [Related]
22. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy.
Ortega JJ; Díaz de Heredia C; Olivé T; Bastida P; Llort A; Armadans L; Torrabadella M; Massuet L
Haematologica; 2003 Mar; 88(3):290-9. PubMed ID: 12651268
[TBL] [Abstract][Full Text] [Related]
23. Risk-adapted pre-emptive therapy for cytomegalovirus disease in patients undergoing allogeneic bone marrow transplantation.
Mori T; Okamoto S; Matsuoka S; Yajima T; Wakui M; Watanabe R; Ishida A; Iwao Y; Mukai M; Hibi T; Ikeda Y
Bone Marrow Transplant; 2000 Apr; 25(7):765-9. PubMed ID: 10745263
[TBL] [Abstract][Full Text] [Related]
24. Clinical strategies for the management of cytomegalovirus infection and disease in allogeneic bone marrow transplant.
Prentice HG; Kho P
Bone Marrow Transplant; 1997 Jan; 19(2):135-42. PubMed ID: 9116610
[TBL] [Abstract][Full Text] [Related]
25. Longitudinal study of bacterial, viral, and fungal infections in adult recipients of bone marrow transplants.
Ninin E; Milpied N; Moreau P; André-Richet B; Morineau N; Mahé B; Vigier M; Imbert BM; Morin O; Harousseau JL; Richet H
Clin Infect Dis; 2001 Jul; 33(1):41-7. PubMed ID: 11389493
[TBL] [Abstract][Full Text] [Related]
26. Effects of norfloxacin or pefloxacin on the oral and intestinal microflora of bone marrow transplant patients.
Giuliano M; Gentile G; Pantosti A; Micozzi A; Arcese W; Martino P
J Chemother; 1989 Jul; 1(4 Suppl):726-7. PubMed ID: 16312609
[No Abstract] [Full Text] [Related]
27. Randomized clinical trial of ganciclovir vs acyclovir for prevention of cytomegalovirus antigenemia after allogeneic transplantation.
Burns LJ; Miller W; Kandaswamy C; DeFor TE; MacMillan ML; Van Burik JA; Weisdorf DJ
Bone Marrow Transplant; 2002 Dec; 30(12):945-51. PubMed ID: 12476289
[TBL] [Abstract][Full Text] [Related]
28. Defective anticarbohydrate antibody responses to naturally occurring bacteria following bone marrow transplantation.
Kapoor N; Chan R; Weinberg KI; Burotto F; Parkman R
Biol Blood Marrow Transplant; 1999; 5(1):46-50. PubMed ID: 10232740
[TBL] [Abstract][Full Text] [Related]
29. Gastrointestinal decontamination in the compromised host and its clinical significance.
Ozawa A; Sawamura S; Yanagawa Y; Nagao T; Sasaki S
Tokai J Exp Clin Med; 1985 Jun; 10(2-3):181-92. PubMed ID: 3914741
[TBL] [Abstract][Full Text] [Related]
30. Late onset of invasive aspergillus infection in bone marrow transplant patients at a university hospital.
Grow WB; Moreb JS; Roque D; Manion K; Leather H; Reddy V; Khan SA; Finiewicz KJ; Nguyen H; Clancy CJ; Mehta PS; Wingard JR
Bone Marrow Transplant; 2002 Jan; 29(1):15-9. PubMed ID: 11840139
[TBL] [Abstract][Full Text] [Related]
31. [Allogeneic bone marrow transplantation in children with severe acquired aplastic anemia. The long-term results. The Spanish Group for Bone Marrow Transplantation in Children (GETMON)].
Muñoz Villa A; Ortega Aramburu JJ; Bureo Dacal E; Badell Serra I; Madero López L; Olive Oliveras T; Cubells Riero J; Maldonado Regalado MS; Ramírez Orellana M
An Esp Pediatr; 1999 Jan; 50(1):29-32. PubMed ID: 10083639
[TBL] [Abstract][Full Text] [Related]
32. [Antimicrobial therapy in patients with bone-marrow transplantation].
Falisevac J
Lijec Vjesn; 1978 Jun; 100(6):391-2. PubMed ID: 359980
[No Abstract] [Full Text] [Related]
33. Pneumopathy in children after bone marrow transplantation. Report from the AIEOP-BMT Registry. The Italian Association of Pediatric Hematology-Oncology BMT Group.
Garaventa A; Rondelli R; Castagnola E; Locatelli F; Dallorso S; Porta F; Uderzo C; Rossetti F; Miniero R; Andolina M; Amici A; Iori AP; Di Bartolomeo P; Dini G; Pession A; Paolucci P; Viscoli C
Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():160-2. PubMed ID: 8932821
[No Abstract] [Full Text] [Related]
34. Bacterial infection.
Benoit DD; Depuydt P; Vandewoude KH
Crit Care Med; 2004 Jan; 32(1):307; author reply 307-8. PubMed ID: 14707607
[No Abstract] [Full Text] [Related]
35. Pooled analysis of two clinical trials comparing the clinical outcomes of topical ciprofloxacin/dexamethasone otic suspension and polymyxin B/neomycin/hydrocortisone otic suspension for the treatment of acute otitis externa in adults and children.
Rahman A; Rizwan S; Waycaster C; Wall GM
Clin Ther; 2007 Sep; 29(9):1950-6. PubMed ID: 18035194
[TBL] [Abstract][Full Text] [Related]
36. Allogeneic bone marrow transplantation in children failing prior autologous bone marrow transplantation.
Hale GA; Tong X; Benaim E; Cunningham JM; Heslop HE; Horwiz EM; Leung W; Rochester RJ; Shearer PD; Srivastava DK; Woodard JP; Bowman LC
Bone Marrow Transplant; 2001 Jan; 27(2):155-62. PubMed ID: 11281384
[TBL] [Abstract][Full Text] [Related]
37. Long-term renal function following bone marrow transplantation.
Grönroos MH; Bolme P; Winiarski J; Berg UB
Bone Marrow Transplant; 2007 Jun; 39(11):717-23. PubMed ID: 17401393
[TBL] [Abstract][Full Text] [Related]
38. [Ear drops otofa and polydexa for treatment of acute external otitis media in children].
Baliasinskaia GL
Vestn Otorinolaringol; 2003; (3):53-4. PubMed ID: 12847812
[No Abstract] [Full Text] [Related]
39. Similar outcome after unrelated allogeneic peripheral blood stem cell transplantation compared with bone marrow in children and adolescents.
Remberger M; Ringdén O
Transplantation; 2007 Aug; 84(4):551-4. PubMed ID: 17713443
[TBL] [Abstract][Full Text] [Related]
40. Liposomal amphotericin B prophylaxis of invasive mold infections in children post allogeneic stem cell transplantation.
Roman E; Osunkwo I; Militano O; Cooney E; van de Ven C; Cairo MS
Pediatr Blood Cancer; 2008 Feb; 50(2):325-30. PubMed ID: 17514732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
